SPENCER STOTT: Open Payments
NPI 1699445601 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,987 in 93 payments from 13 companies in 2025. Trend: 2023 $1,100 · 2024 $1,567 · 2025 $1,987
Food & beverage: $1,985Education: $2
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $544 |
| Vanda Pharmaceuticals Inc. | 15 | $432 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $239 |
| Alkermes, Inc. | 6 | $209 |
| Bausch Health US, LLC | 9 | $187 |
| Lundbeck LLC | 7 | $150 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Corium, LLC | 2 | $29 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
Products named: VRAYLAR, FANAPT, CAPLYTA, LYBALVI, APLENZIN, REXULTI, COBENFY, ABILIFY MAINTENA.
Industry payments across AZ — which companies pay providers there.
